DocSym
β
Searchsearch
Search
(M08.3) Juvenile polyarthritis (seronegative)
More details coming soon
953 450 in individuals diagnosis juvenile polyarthritis (seronegative) confirmed
2 697 deaths with diagnosis juvenile polyarthritis (seronegative)
Diagnosis juvenile polyarthritis (seronegative) is diagnosed Women are 26.61% more likely than Men
349 850
Men receive the diagnosis juvenile polyarthritis (seronegative)
1 151 (0.3 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
603 600
Women receive the diagnosis juvenile polyarthritis (seronegative)
1 546 (0.3 %)Died from this diagnosis.
Risk Group for the Disease juvenile polyarthritis (seronegative) - Men and Women aged 10-14
In Men diagnosis is most often set at age 0-64, 70-74, 80-84
Less common in men the disease occurs at Age 0-1, 65-69, 75-79, 85-95+Less common in women the disease occurs at Age 90-94
In Women diagnosis is most often set at age 0-89, 95+
Disease Features juvenile polyarthritis (seronegative)
Absence or low individual and public risk
Juvenile polyarthritis (seronegative) - what does this mean
Juvenile polyarthritis (seronegative) is an autoimmune disorder that occurs when the body's immune system mistakenly attacks healthy tissue in the joints, leading to inflammation and joint pain. it is a form of arthritis that usually affects children under the age of 16 and is characterized by joint swelling, stiffness, and pain. it is a seronegative form of arthritis, meaning that it is not associated with the presence of certain antibodies in the blood.
What happens during the disease - juvenile polyarthritis (seronegative)
Juvenile polyarthritis (seronegative) is an autoimmune disorder that is characterized by inflammation of the joints in children. it is believed to be caused by an aberrant immune response to an unknown environmental trigger, leading to the production of autoantibodies that attack the joints. this results in joint pain, swelling, and stiffness, as well as systemic symptoms such as fever, fatigue, and anemia. treatment typically involves the use of immunosuppressive drugs and physical therapy to reduce inflammation and improve joint function.
Clinical Pattern
More details coming soon
How does a doctor diagnose
More details coming soon
Treatment and Medical Assistance
More details coming soon
12 Days of Hospitalization Required
50 Hours Required for Outpatient Treatment
Juvenile polyarthritis (seronegative) - Prevention
Juvenile polyarthritis (seronegative) can be prevented by avoiding contact with people who are ill, washing hands frequently, eating a healthy diet, and getting regular exercise. vaccinations can also help reduce the risk of developing this condition.